US › Healthcare

ReWalk Robotics Ltd (LFWD)

US · Healthcare · Medical Devices

$6.96+0.72%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$6.6M

Revenue YoY

+15.7%

Net profit

$-11.5M

EPS

$-1.46

EPS estimate

$-1.49

Net margin

-173.9%

EPS came in at -1.46 against a street estimate of -1.49 — a beat of 2.0%.

Key statistics

Market cap

$20.2M

Forward P/E

0.0

P/B

1.65

Book value

$4.32

EPS (TTM)

$-14.66

52-week high

$10.56

52-week low

$4.14

50-day MA

$7.50

200-day MA

$7.19

Beta

0.40

Analyst view

Analysts rate ReWalk Robotics Ltd a buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $20.00.

Shareholding

Insiders

47.87%

Institutions

1.45%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.64%
Renaissance Technologies Corp	0.40%
UBS Group AG	0.07%
Morgan Stanley - Brokerage Accounts	0.01%
SBI Securities Co Ltd	0.01%
Advisor Group Holdings, Inc.	0.00%
NATIONAL BANK OF CANADA /FI/	0.00%
Caitong International Asset Management Co., Limited.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for ReWalk Robotics Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.